Trial
NCT02944864
A Phase I Study of TQ-B3395 on Tolerance and Pharmacokinetics
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Collaborators
—
Condition
Advanced Cancer
Intervention
TQ-B3395
Why stopped
Per sponsor request.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-09-23